.
MergerLinks Header Logo

New Deal


Announced

Intersect ENT to acquire Fiagon's Medical Technologies for $71m.

Financials

Edit Data
Transaction Value£55m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

brain navigation

ent navigation

Acquisition

Pending

medical technologies

Private

Germany

Cross Border

Majority

Friendly

medical devices

Medical Equipment

Single Bidder

Synopsis

Edit

Intersect ENT, a company transforming care for patients with ear, nose and throat conditions to acquire Medical Technologies business of Fiagon, a surgical navigation solutions, for $71m. “We are excited to join the team at Intersect ENT, an established leader with an advanced therapeutic platform in the large and attractive global ENT market. The combination of Intersect ENT’s compelling product offerings coupled with its deep commercial leadership expertise and impressive sales force offers a unique opportunity for us to jointly leverage our core innovation and commercialization competencies. We look forward to working with the Intersect ENT team to expand market penetration of our instruments and tools globally," Kai Desinger, Fiagon President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US